ATE454392T1 - Rekombinante, 56 bzw. 82 kda grosse antigene aus gametozyten von eimeria maxima codierende nukleinsäuren und ihre verwendungen - Google Patents

Rekombinante, 56 bzw. 82 kda grosse antigene aus gametozyten von eimeria maxima codierende nukleinsäuren und ihre verwendungen

Info

Publication number
ATE454392T1
ATE454392T1 AT02746870T AT02746870T ATE454392T1 AT E454392 T1 ATE454392 T1 AT E454392T1 AT 02746870 T AT02746870 T AT 02746870T AT 02746870 T AT02746870 T AT 02746870T AT E454392 T1 ATE454392 T1 AT E454392T1
Authority
AT
Austria
Prior art keywords
eimeria
kda
recombinant
provides
subject invention
Prior art date
Application number
AT02746870T
Other languages
English (en)
Inventor
Sabina L Belli
Nicolas C Smith
Michael Wallach
Original Assignee
Abic Biolog Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abic Biolog Lab Ltd filed Critical Abic Biolog Lab Ltd
Application granted granted Critical
Publication of ATE454392T1 publication Critical patent/ATE454392T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/455—Eimeria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02746870T 2001-07-06 2002-07-03 Rekombinante, 56 bzw. 82 kda grosse antigene aus gametozyten von eimeria maxima codierende nukleinsäuren und ihre verwendungen ATE454392T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30369901P 2001-07-06 2001-07-06
PCT/US2002/021233 WO2003004683A2 (en) 2001-07-06 2002-07-03 Nucleic acids encoding recombinant 56 and 82 kda antigens from gametocytes of eimeria maxima and their uses

Publications (1)

Publication Number Publication Date
ATE454392T1 true ATE454392T1 (de) 2010-01-15

Family

ID=23173289

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02746870T ATE454392T1 (de) 2001-07-06 2002-07-03 Rekombinante, 56 bzw. 82 kda grosse antigene aus gametozyten von eimeria maxima codierende nukleinsäuren und ihre verwendungen

Country Status (18)

Country Link
US (2) US7423137B2 (de)
EP (1) EP1432722B1 (de)
JP (2) JP2005501533A (de)
CN (1) CN1606565B (de)
AT (1) ATE454392T1 (de)
AU (1) AU2002316558B2 (de)
BR (1) BR0210853A (de)
CA (1) CA2467006A1 (de)
DE (1) DE60235021D1 (de)
ES (1) ES2339227T3 (de)
HU (1) HUP0600028A3 (de)
IL (2) IL159716A0 (de)
MX (1) MXPA04000127A (de)
PL (1) PL366540A1 (de)
RU (1) RU2004103469A (de)
TR (1) TR200400049T2 (de)
WO (1) WO2003004683A2 (de)
ZA (1) ZA200400479B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0775746T3 (da) * 1995-07-03 2006-04-03 Akzo Nobel Nv Vaccine mod fjerkræcoccidiose
ZA200400479B (en) 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use
CN100348608C (zh) 2001-07-06 2007-11-14 Abic特瓦生物实验室有限公司 编码重组的来源于巨型艾美球虫子孢子/裂殖子的250kDa抗原的核酸,和它们的应用
PL2066339T3 (pl) 2006-09-18 2015-02-27 Univ Arkansas Kompozycje i sposoby zwiększania odpowiedzi immunologicznych
PT3097926T (pt) * 2007-11-01 2020-01-08 Univ Guelph Composições e métodos de potenciação das respostas imunitárias frente a eimeria
US20100150958A1 (en) * 2008-12-15 2010-06-17 Vectogen Pty Ltd. Methods and Compositions for Use of a Coccidiosis Vaccine
AR094791A1 (es) 2013-02-14 2015-08-26 Univ Arkansas Composiciones y métodos para mejorar las respuestas inmunes ante una infección por eimeria o para limitar una infección por eimeria
AU2015263877B2 (en) * 2014-05-23 2021-01-21 Desert King International Llc Combination, composition, and method of administering the combination or composition to animals
CN111471107B (zh) * 2020-04-27 2023-04-18 中国农业大学 抗鸡球虫多价重组蛋白卵黄抗体及其制备方法和应用
CN111840529B (zh) * 2020-07-30 2023-08-25 广东省农业科学院动物卫生研究所 一种柔嫩艾美耳球虫重组多肽疫苗vkvq的制备及其在抗鸡球虫病中的应用方法
CN113521264A (zh) * 2021-07-14 2021-10-22 中国农业科学院北京畜牧兽医研究所 一种鸽球虫病活疫苗及其制备方法和应用
CN114051971B (zh) * 2021-08-26 2023-08-29 山东农巧农业科技有限公司 一种高效率乳鸽生态养殖方法
CN114736308B (zh) * 2022-03-15 2022-12-27 四川宜美康科技有限公司 球虫抗原肽/il5的融合蛋白基因工程菌的制备及用途
CN116212009A (zh) * 2022-12-15 2023-06-06 四川农业大学 兔球虫重组蛋白在防控兔球虫病中的应用
CN118360158B (zh) * 2024-05-14 2024-10-29 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 柔嫩艾美耳球虫卵囊壁蛋白6（EtOWP6）缺失弱毒株、构建方法、组合物及其应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135712A3 (de) 1983-08-19 1987-05-27 American Cyanamid Company Gegen Sporozoiten von Eimeria Spp. reaktive monoklonale Antikörper und Antigene
CA1340520C (en) 1984-06-05 1999-05-04 Karel Z. Newman Jr. Antigenic proteins and vaccines containing them and protective antibodies directed to them for prevention of coccidiosis caused by eimeria tenella and eimeria necatrix
US4639372A (en) 1984-06-29 1987-01-27 Merck & Co., Inc. Coccidiosis vaccine
WO1990000403A1 (en) 1988-07-05 1990-01-25 Genex Corporation Genetically engineered coccidiosis vaccine
US5496550A (en) * 1986-08-14 1996-03-05 Chilwalner Method of reducing the output of Eimeria oocysts from a newborn chick
CA1340838C (en) 1986-08-14 1999-12-07 Michael Wallach Coccidiosis vacine
ZA893740B (en) * 1988-06-03 1990-02-28 Hoffmann La Roche Recombinant coccidiosis vaccines
ZA200400479B (en) 2001-07-06 2006-05-31 Abic Biolog Lab Teva Nucleic acids encoding recombinant 56 a 82 KDA antigens from gametocytes of Eimeria maxima and their use

Also Published As

Publication number Publication date
US20050033042A1 (en) 2005-02-10
EP1432722A2 (de) 2004-06-30
IL159716A0 (en) 2004-06-20
TR200400049T2 (tr) 2009-01-21
HUP0600028A2 (en) 2006-04-28
ZA200400479B (en) 2006-05-31
US20090196888A1 (en) 2009-08-06
BR0210853A (pt) 2005-08-30
AU2002316558B2 (en) 2009-01-08
ES2339227T3 (es) 2010-05-18
DE60235021D1 (de) 2010-02-25
EP1432722A4 (de) 2005-08-10
CN1606565B (zh) 2011-06-29
RU2004103469A (ru) 2005-04-10
US7423137B2 (en) 2008-09-09
CA2467006A1 (en) 2003-01-16
IL159716A (en) 2010-06-16
WO2003004683A3 (en) 2004-04-29
HUP0600028A3 (en) 2010-01-28
MXPA04000127A (es) 2005-07-01
JP2005501533A (ja) 2005-01-20
WO2003004683A2 (en) 2003-01-16
EP1432722B1 (de) 2010-01-06
CN1606565A (zh) 2005-04-13
US7968695B2 (en) 2011-06-28
JP2009077713A (ja) 2009-04-16
PL366540A1 (en) 2005-02-07

Similar Documents

Publication Publication Date Title
ATE454392T1 (de) Rekombinante, 56 bzw. 82 kda grosse antigene aus gametozyten von eimeria maxima codierende nukleinsäuren und ihre verwendungen
Dziadek et al. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis
EA200700849A1 (ru) Первичная/бустерная противомалярийная вакцина
Lillehoj et al. Embryo vaccination against Eimeria tenella and E. acervulina infections using recombinant proteins and cytokine adjuvants
ATE80310T1 (de) Antigenische proteine, dieselben enthaltende vakzine, schuetzende antikoerper dagegen fuer die verhuetung von durch eimeria tenella verursachte coccidiosis.
Dziadek et al. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis
CA2508757A1 (en) Coccidial vaccine and methods of making and using same
Horii et al. Characterization of antigen-expressing Plasmodium falciparum cDNA clones that are reactive with parasite inhibitory antibodies
Golshani et al. Comparison of potential protection conferred by three immunization strategies (protein/protein, DNA/DNA, and DNA/protein) against Brucella infection using Omp2b in BALB/c Mice
ATE454394T1 (de) Rekombinantes, 250 kda grosses antigen aus sporozoiten/merozoiten von eimeria maxima codierende nukleinsäuren und ihre verwendungen
Serezani et al. Evaluation of the murine immune response to Leishmania meta 1 antigen delivered as recombinant protein or DNA vaccine
Hedhli et al. The antigen-specific response to Toxoplasma gondii profilin, a TLR11/12 ligand, depends on its intrinsic adjuvant properties
Rafati et al. Leishmania infantum: prime boost vaccination with C-terminal extension of cysteine proteinase type I displays both type 1 and 2 immune signatures in BALB/c mice
EP2658568A1 (de) Impfstoffantigen von babesiose des hundes
ZA202309225B (en) Immunogenic fusion protein
EP1090995A3 (de) Mycoplasma hyopneumoniae Antigen MHP3, dafür kodierendes Gen und Ihre Verwendungen
CA2531329A1 (en) Family of 28 kda babesia proteins as vaccines
KR890000106A (ko) 원생성 기생충 예방용 백신
Schmidt-Ullrich et al. Rhesus monkeys protected against Plasmodium knowlesi malaria produce antibodies against a 65,000-MrP. knowlesi glycoprotein at the surface of infected erythrocytes
Tabatabaie et al. Cloning and sequencing of Leishmania major thiol-specific-antioxidant antigen (TSA) gene
DE69233271D1 (de) Therapeutischer- und präventivimpfstoff gegen hiv
Khosroshahi et al. Expression of complete rhoptry protein 2 (ROP2) gene of Toxoplasma gondii in eukaryotic cell
WO2005026199A2 (en) Piroplasmid vaccine
TH77236A (th) การเข้ารหัสกรดนิวคลีอิคของรีคอมบิแนนท์ 56 และ 82 kDa แอนติเจนจากแกมีโตไซต์ของ Eimeria maxima และการใช้งานของมัน
Mayahi Cloning and expression of Eimeria necatrix microneme5 gene in Escherichia coli

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties